CoChat

The multiple myelomas — current concepts in cytogenetic classification and therapy

Kumar, Shaji K., Rajkumar, S. Vincent · 2018 · Nature Reviews Clinical Oncology

The DOI matches its Crossref record; 125 of the 126 references it cites were found in a registry or an index.

Abstract

Multiple myeloma (MM) is a plasma cell neoplasm that accounts for 2% of all haematological malignancies and predominantly affects older individuals (with a median age at diagnosis of 65-70 years). MM is consistently preceded by the clinically recognized precancerous stages monoclonal gammopathy of undetermined significance and smouldering MM. Thus far, MM has been considered as a single disease entity, but the clinical presentation, response to treatment, and survival outcomes of patients with MM are quite heterogeneous and highly dependent on a set of chromosomal abnormalities that can be identified in nearly all of them. These alterations include primary cytogenetic abnormalities, such as translocations involving chromosome 14q and trisomies of odd-numbered chromosomes, as well as secondary abnormalities, such as deletion of chromosome 17p and amplification of chromosome 1q. The aetiology of myeloma is poorly understood, although different nonoverlapping disease entities can be defined on the basis of their specific primary cytogenetic abnormalities, which have a major role in determining clinical behaviour. This classification might enable the development of better treatment strategies focused on the underlying biology of each specific subtype. Herein, we describe treatment approaches that incorporate the current standard of care for patients with MM along with recommended alterations or improvements that might provide additional clinical benefit for certain subgroups of p…

Overview

Integrity signals

Registry

Crossref · 10.1038/s41571-018-0018-y

Cites

125 of 125 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

Show all 125 references

Research works printed but not linked: 1

  1. Cavo, M. et al. Double autologous stem cell transplantation significantly prolongs progression-free survival and overall survival in comparison with single autotransplantation in newly diagnosed multiple myeloma: an analysis of phase 3 EMN02/HO95 study. Blood 130, 401–401 (2017).

Cited by

See all 341

Metadata

Authors
Kumar, S. K., & Rajkumar, S. V.
Affiliations
Mayo Clinic (US)
Corresponding author
Kumar, Shaji K.
Venue
Nature Reviews Clinical Oncology
Published
2018-04-23
Volume
15
Issue
7
Pages
409-421
ISSN
  • 1759-4774 (ISSN-L)
  • 1759-4782
OpenAlex
W2799981419
Cited by
302
References
126
Citations by year
2026: 22 · 2025: 30 · 2024: 44 · 2023: 44 · 2022: 43 · 2021: 40 · 2020: 40 · 2019: 31 · 2018: 8
FWCI
4.90
Type
journal article
Language
en
Open access
closed
Licence
www.springer.com/tdm (tdm)
Locations
  • Nature Reviews Clinical Oncology (publishedVersion)
  • PubMed (publishedVersion)
Funders
  • National Institutes of Health (CA186781)
  • National Cancer Institute (R01CA107476, R01CA168762, P50CA186781)
Topics
  • Health Sciences › Medicine › Hematology › Multiple Myeloma Research and Treatments
  • Health Sciences › Medicine › Hematology › Chronic Lymphocytic Leukemia Research
  • Health Sciences › Medicine › Pathology and Forensic Medicine › Lymphoma Diagnosis and Treatment
Keywords
multiple myeloma, cytogenetic classification, chromosomal abnormalities, monoclonal gammopathy of undetermined significance, smoldering multiple myeloma, trisomy 19, Down syndrome, chromosome 17p deletion, chromosome 1q amplification, plasma cell neoplasms, disease heterogeneity
MeSH terms
Age Factors, Aged, Chromosome Aberrations, Chromosome Deletion, Chromosomes, Human, Pair 14, Humans, Monoclonal Gammopathy of Undetermined Significance, Multiple Myeloma, Translocation, Genetic

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: The multiple myelomas — current concepts in cytogenetic classification and therapy. https://app.cochat.ai/papers/10.1038/s41571-018-0018-y
The paper
Kumar, S. K., & Rajkumar, S. V. (2018). The multiple myelomas — current concepts in cytogenetic classification and therapy. Nature Reviews Clinical Oncology. https://doi.org/10.1038/s41571-018-0018-y

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.